Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus

Novartis

Status and phase: Completed; Phase 4

Conditions: Hypertension; Type 2 Diabetes; PROTEINURIA

Treatments: Drug: valsartan

Study type: Interventional

Funder types: Industry

Identifiers

NCT00241085

CVAL489A2417

Details and patient eligibility

About

This is a study of whether valsartan affects levels of proteinuria in patients with type 2 diabetes and hypertension.

Enrollment: 392 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Mild to moderate hypertension, Mild renal dysfunction, Type 2 diabetes,

Exclusion criteria

Pregnant or breast feeding, Type 1 diabetes

Other protocol criteria apply

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind